Of the over 110,000 Kenyan children currently living with HIV, 82% are receiving life-saving antiretroviral therapy (ART). Thanks in part to the work of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), ART coverage for adults and children has increased over 40% since 2013.

About the Program

EGPAF began working in Kenya in 2000. The program started as a small, privately-funded PMTCT initiative and has since grown into one of the largest HIV prevention, care and treatment programs in the country. EGPAF-Kenya aims to implement sustainable programs that support Kenya’s government toward its mission to end pediatric AIDS. To succeed in this, EGPAF collaborates with multiple partners, including Kenya’s Ministry of Health at national and county levels, supporting implementation of PMTCT and HIV care and treatment services. EGPAF-Kenya also provides essential technical and organizational capacity-building assistance to community-based organizations throughout our supported regions.

EGPAF-Kenya participates in national HIV and AIDS technical advisory committees for PMTCT, adult and pediatric HIV treatment, HIV prevention, and monitoring and evaluation.  We are also dedicated to advancing basic and operations research to strengthen the effectiveness of the global HIV and AIDS response.

Our Impact

Antiretroviral therapy to nearly 86,000 adults and 6,500 children

PMTCT services to over 5,000 pregnant women

HIV testing services to over 390,000 individuals

The Latest from Kenya

health workers in eswatini

Story

The Heart of Global Health

Published March 2025

Every day, all around the world, health workers are making a difference. Some are on the frontlines providing direct services to people needing care. Others lend their technical skills in labs and pharmacies. Some work on a systems level, ensuring all of the complex pieces of health care are working together. But one thing unites […]

Topics:

General

Countries:

Kenya,

Malawi,

Nigeria,

Tanzania,

Uganda

Kenya

Journal Articles

Assessing Time Requirements of Two Models of SARS-CoV- 2 Screening and Testing in Routine Healthcare Services in Kenya and Cameroon

Published March 2025

Introduction Incorporating SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) into routine care settings can facilitate efficient case identification and management in low-resource settings. We assessed the time required to complete SARS-CoV-2 screening and Ag-RDT testing in maternal, neonatal and child health (MNCH), HIV and tuberculosis clinics in selected facilities in Kenya and Cameroon. Methods We conducted […]

Countries:

Cameroon,

Kenya

Kenya

Journal Articles

A Cross-Sectional Study of the Use of Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus-2 in Kenya

Published January 2025

Overview Mass testing with antigen-detecting rapid diagnostic tests (Ag-RDT), including testing of asymptomatic individuals, is expected to improve the identification of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Mass testing was offered at large gatherings to determine the SARS-CoV-2 case detection rate and the acceptance and cost of implementing this community testing strategy. In 49 […]

Countries:

Kenya